Treatment of refractory idiopathic overactive bladder with incobotulinumtoxinA and vibe delivery system (XAVIER): pilot study.

Schwarztuch Gildor O, Geva A, Eftel A, Branco F, Xambre L, Dmochowski RR, Vainrib M, XAVIER Study Group.

DOI: 10.23736/s2724-6051.26.06822-9
Published: 2026-05-20
Container: Minerva Urol Nephrol
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.23736/s2724-6051.26.06822-9,
  title = {Treatment of refractory idiopathic overactive bladder with incobotulinumtoxinA and vibe delivery system (XAVIER): pilot study.},
  author = {Schwarztuch Gildor O and  Geva A and  Eftel A and  Branco F and  Xambre L and  Dmochowski RR and  Vainrib M and  XAVIER Study Group.},
  year = {2026},
  journal = {Minerva Urol Nephrol},
  doi = {10.23736/s2724-6051.26.06822-9},
  url = {https://doi.org/10.23736/s2724-6051.26.06822-9}
}

RIS

TY  - JOUR
TI  - Treatment of refractory idiopathic overactive bladder with incobotulinumtoxinA and vibe delivery system (XAVIER): pilot study.
AU  - Schwarztuch Gildor O
AU  -  Geva A
AU  -  Eftel A
AU  -  Branco F
AU  -  Xambre L
AU  -  Dmochowski RR
AU  -  Vainrib M
AU  -  XAVIER Study Group.
PY  - 2026
JO  - Minerva Urol Nephrol
DO  - 10.23736/s2724-6051.26.06822-9
UR  - https://doi.org/10.23736/s2724-6051.26.06822-9
ER  -

APA

O, S. G., A, G., A, E., F, B., L, X., RR, D., M, V., & Group., X. S. (2026). Treatment of refractory idiopathic overactive bladder with incobotulinumtoxinA and vibe delivery system (XAVIER): pilot study.. Minerva Urol Nephrol. https://doi.org/10.23736/s2724-6051.26.06822-9

Source records

europe-pmc · retrieved 2026-09-25T21:26:27.594Z